{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T13:55:45Z","timestamp":1724853345080},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360029"],"award-info":[{"award-number":["82360029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Commissioned Project of National Clinical Medicine Research Center for Hematological System Diseases","award":["2021WWA01"],"award-info":[{"award-number":["2021WWA01"]}]},{"name":"the Clinical Medical Research Center of Hematological Diseases in Gansu Province","award":["21JR7RA435"],"award-info":[{"award-number":["21JR7RA435"]}]},{"name":"the Natural Science Foundation of Science and Technology Program of Gansu Province","award":["21JR7RA394"],"award-info":[{"award-number":["21JR7RA394"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70332-7","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T18:03:34Z","timestamp":1724177014000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of different conditioning regimens on HLA-mismatched microtransplantation and changes in fine immune indices in acute myeloid leukaemia"],"prefix":"10.1038","volume":"14","author":[{"given":"Zheng","family":"Hanxue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zilu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Liansheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Lijuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"70332_CR1","first-page":"2813","volume":"141","author":"F El Chaer","year":"2023","unstructured":"El Chaer, F., Hourigan, C. S. & Zeidan, A. M. How I treat AML incorporating the updated classifications and guidelines. Blood 141, 2813\u20132823 (2023).","journal-title":"Blood"},{"key":"70332_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","volume":"21","author":"DA Pollyea","year":"2023","unstructured":"Pollyea, D. A. et al. Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 21, 503\u2013513 (2023).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"70332_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood.2023022481","volume":"143","author":"F Thol","year":"2024","unstructured":"Thol, F., D\u00f6hner, H. & Ganser, A. How I treat refractory and relapsed acute myeloid leukemia. Blood 143, 11\u201320 (2024).","journal-title":"Blood"},{"key":"70332_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali, R. S., Pratz, K. W. & Lai, C. Recent advances in targeted therapies in acute myeloid leukemia. J. Hematol. Oncol. 16, 29 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"70332_CR5","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell, L. F. & Cook, R. J. Advances in acute myeloid leukemia. BMJ 375, n2026 (2021).","journal-title":"BMJ"},{"key":"70332_CR6","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","volume":"11","author":"O Penack","year":"2024","unstructured":"Penack, O. et al. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: Updated consensus recommendations of the European society for blood and marrow transplantation. Lancet Haematol. 11, e147\u2013e159 (2024).","journal-title":"Lancet Haematol."},{"key":"70332_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","volume":"9","author":"F Malard","year":"2023","unstructured":"Malard, F., Holler, E., Sandmaier, B. M., Huang, H. & Mohty, M. Acute graft-versus-host disease. Nat. Rev. Dis. Primers 9, 27 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"70332_CR8","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1016\/S2352-3026(22)00293-9","volume":"9","author":"YJ Chang","year":"2022","unstructured":"Chang, Y. J., Pei, X. Y. & Huang, X. J. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: Current advances, challenges, and future directions. Lancet Haematol. 9, e919\u2013e929 (2022).","journal-title":"Lancet Haematol."},{"key":"70332_CR9","doi-asserted-by":"publisher","first-page":"e777","DOI":"10.1016\/S2352-3026(23)00114-X","volume":"10","author":"C Sp\u00e4th","year":"2023","unstructured":"Sp\u00e4th, C., Neumann, T., Schmidt, C. A., Heidel, F. H. & Kr\u00fcger, W. H. Patients receiving allogeneic haematopoietic stem-cell transplantation and clinical outcomes after early access to palliative care. Lancet Haematol. 10, e777\u2013e784 (2023).","journal-title":"Lancet Haematol."},{"key":"70332_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood-2010-06-288506","volume":"117","author":"M Guo","year":"2011","unstructured":"Guo, M. et al. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood 117, 936\u2013941 (2011).","journal-title":"Blood"},{"key":"70332_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamaoncol.2017.2656","volume":"4","author":"M Guo","year":"2018","unstructured":"Guo, M. et al. HLA-mismatched microtransplant in older patients newly diagnosed with acute myeloid leukemia: Results from the microtransplantation interest group. JAMA Oncol. 4, 54\u201362 (2018).","journal-title":"JAMA Oncol."},{"key":"70332_CR12","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1200\/JCO.2012.42.0281","volume":"30","author":"M Guo","year":"2012","unstructured":"Guo, M. et al. HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: Long-term follow-up. J. Clin. Oncol. 30, 4084\u20134090 (2012).","journal-title":"J. Clin. Oncol."},{"key":"70332_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202\u2013208 (2013).","journal-title":"Nat. Med."},{"key":"70332_CR14","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1016\/S2352-3026(22)00076-X","volume":"9","author":"CA Lachowiez","year":"2022","unstructured":"Lachowiez, C. A. et al. Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: A post-hoc, propensity score-matched, cohort study. Lancet Haematol. 9, e350\u2013e360 (2022).","journal-title":"Lancet Haematol."},{"key":"70332_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S1470-2045(18)30010-X","volume":"19","author":"CD DiNardo","year":"2018","unstructured":"DiNardo, C. D. et al. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: A non-randomised, open-label, phase 1b study. Lancet Oncol. 19, 216\u2013228 (2018).","journal-title":"Lancet Oncol."},{"key":"70332_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo, C. D. et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N. Engl. J. Med. 383, 617\u2013629 (2020).","journal-title":"N. Engl. J. Med."},{"key":"70332_CR17","first-page":"1532","volume":"15","author":"L Wang","year":"2018","unstructured":"Wang, L., Du, F., Wang, H. & Xie, C. Cooperation of CD4(+) T cells and CD8(+) T cells and release of IFN-\u03b3 are critical for antileukemia responses of recipient mice treated by microtransplantation. Exp. Ther. Med. 15, 1532\u20131537 (2018).","journal-title":"Exp. Ther. Med."},{"key":"70332_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1089\/scd.2019.0295","volume":"29","author":"KX Hu","year":"2020","unstructured":"Hu, K. X. et al. Donor selection in HLA-mismatched hematopoietic stem cell microtransplantation for acute myeloid leukemia. Stem Cells Dev. 29, 648\u2013654 (2020).","journal-title":"Stem Cells Dev."},{"key":"70332_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1479-5876-11-150","volume":"11","author":"JL Reagan","year":"2013","unstructured":"Reagan, J. L. et al. Cellular immunotherapy for refractory hematological malignancies. J. Transl. Med. 11, 150 (2013).","journal-title":"J. Transl. Med."},{"key":"70332_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1389450116666150304103849","volume":"18","author":"EF Krakow","year":"2017","unstructured":"Krakow, E. F. et al. Do we need full donor chimerism? How alloreactive cell therapies without substantial engraftment might treat hematologic cancers. Curr. Drug Targets 18, 281\u2013295 (2017).","journal-title":"Curr. Drug Targets"},{"key":"70332_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbmt.2003.10.006","volume":"10","author":"DR Couriel","year":"2004","unstructured":"Couriel, D. R. et al. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol. Blood Marrow Transplant. 10, 178\u2013185 (2004).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"70332_CR22","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.leukres.2014.08.018","volume":"38","author":"X Sun","year":"2014","unstructured":"Sun, X. et al. The existence and role of microchimerism after microtransplantion. Leuk. Res. 38, 1285\u20131290 (2014).","journal-title":"Leuk. Res."},{"key":"70332_CR23","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1182\/blood-2011-07-367987","volume":"119","author":"N Sawamukai","year":"2012","unstructured":"Sawamukai, N. et al. Cell-autonomous role of TGF\u03b2 and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD. Blood 119, 5575\u20135583 (2012).","journal-title":"Blood"},{"key":"70332_CR24","first-page":"1509","volume":"13","author":"KX Hu","year":"2023","unstructured":"Hu, K. X. et al. Hematopoietic stem cell microtransplantation in patients aged over 70 with acute myeloid leukemia: A multicenter study. Am. J. Cancer Res. 13, 1509\u20131521 (2023).","journal-title":"Am. J. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70332-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T18:07:02Z","timestamp":1724177222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70332"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70332-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19301"}}